MedPath

CARBOPROST TROMETHAMINE

Carboprost Tromethamine Injection, USP

Approved
Approval ID

42736d6a-0ab3-4c3c-897d-406aad5a49c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2023

Manufacturers
FDA

Caplin Steriles Limited

DUNS: 650744670

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

carboprost tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65145-132
Application NumberANDA216882
Product Classification
M
Marketing Category
C73584
G
Generic Name
carboprost tromethamine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateFebruary 22, 2023
FDA Product Classification

INGREDIENTS (6)

CARBOPROST TROMETHAMINEActive
Quantity: 250 ug in 1 mL
Code: U4526F86FJ
Classification: ACTIM
TROMETHAMINEInactive
Quantity: 83 ug in 1 mL
Code: 023C2WHX2V
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CARBOPROST TROMETHAMINE - FDA Drug Approval Details